• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT XL VASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT XL VASCULAR STENT Back to Search Results
Catalog Number EX061703C
Device Problems Fracture (1260); Material Twisted/Bent (2981)
Patient Problems Stenosis (2263); Thrombosis/Thrombus (4440)
Event Date 04/03/2023
Event Type  Injury  
Event Description
It was reported that one month and nineteen days post stent placement in superficial femoral and popliteal artery via left common femoral artery access, an arteriographic examination revealed that the stent allegedly fractured in the median area of the femoral stent.It was further reported that another arteriographic examination revealed that the stent was allegedly found with thrombosis and fractured in the middle third.It was also reported that thrombectomy and angioplasty were performed for fracture of the stent mesh resulted in a complete fracture of the stent, allowing the passage of material to finish the thrombectomy.Furthermore, a large number of thrombi, and intrastent stenosis were observed after thrombectomy.Reportedly, further angioplasty was performed and coated stents were positioned performing endo bridge covering areas of thrombi and stent fracture.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the lifestent xl vascular stent products that are cleared in the us.The pro code and 510 k number for the lifestent xl vascular stent products are identified in d2 and g4.H10: as the lot number for the device was provided, a review of the device history records will be performed.The device has not been returned to the manufacturer for evaluation.However, images and videos were provided for review.The investigation of the reported event is currently underway.H10: d4 (expiry date: 03/2024).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported that one month and nineteen days post stent placement in superficial femoral and popliteal artery via left common femoral artery access, an arteriographic examination revealed that the stent allegedly fractured in the median area of the femoral stent.It was further reported that another arteriographic examination revealed that the stent was allegedly found with thrombosis and fractured in the middle third.It was also reported that thrombectomy and angioplasty were performed for fracture of the stent mesh resulted in a complete fracture of the stent, allowing the passage of material to finish the thrombectomy.Furthermore, a large number of thrombi, and intrastent stenosis were observed after thrombectomy.Reportedly, further angioplasty was performed and coated stents were positioned performing endo bridge covering areas of thrombi and stent fracture.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the lifestent xl vascular stent products that are cleared in the us.The pro code and 510 k number for the lifestent xl vascular stent products are identified in d2 and g4.H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: the physical device was not returned for evaluation.Provided x-ray images and video files confirm a twisted section of the stent placed in the superficial femoral artery.The stent was placed overlapping with another stent, and the twisted section was found just below the overlapping zone.The alleged stent fracture could not be verified.Therefore, based on the information available, it is confirmed that the stent placed in the femoral artery got twisted.A definite root cause for the reported event could not be determined.Labeling review: relevant labeling supplied with this product was reviewed.Proper method for stent deployed was found to be addressed; in particular the instructions for use states: "confirm that the introducer sheath is secure and will not move during deployment.To ensure the most accurate placement, firmly hold the black system stability sheath throughout deployment.Do not hold the silver stent delivery sheath at any time during deployment.Do not constrict the stent delivery sheath during stent deployment.Initiate stent deployment by rotating the thumbwheel in the direction of the arrows, while holding the handle in a fixed position".Regarding preparation the instructions for use states: "predilation of the lesion should be performed using standard techniques" and "gain femoral access utilizing a 6f (2.0 mm) or larger introducer sheath.Insert a 0.035inch (0.89 mm) diameter guidewire of appropriate length".H10: d4 (expiration date: 03/2024), g3 h11: h6 (method, result, conclusion) h11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT XL VASCULAR STENT
Type of Device
VASCULAR STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM   76227
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key16901282
MDR Text Key314887537
Report Number9681442-2023-00177
Device Sequence Number1
Product Code NIP
UDI-Device Identifier04049519001500
UDI-Public(01)04049519001500
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P070014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberEX061703C
Device Lot NumberANGQ0569
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/11/2023
Initial Date FDA Received05/10/2023
Supplement Dates Manufacturer Received07/25/2023
Supplement Dates FDA Received08/01/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
-
-